New drug trial to treat sepsis in babies underway
1 June 2023
1 June 2023
A new clinical trial that hopes to advance the treatment of neonatal sepsis is underway.
Neonatal sepsis is an infection that affects about three million babies worldwide per year and is caused by a systemic bacterial infection. It is a major cause of paediatric deaths. The trial dubbed ‘NeoSep1’ aims to evaluate new combinations of existing antibiotics and compare them with existing treatment regimens used in newborn babies with suspected neonatal sepsis.
The study aims to assess the safety and efficacy of three new combinations of older antibiotics (fosfomycin- amikacin, flomoxef-amikacin, and flomoxef-fosfomycin) against the current standard of care.